Latest news with #AccessVascular
Associated Press
29-04-2025
- Health
- Associated Press
Expanded Real-World Data Presented at INS 2025 Reinforces Better Outcomes with Access Vascular's Hydrophilic Midline Catheter
BILLERICA, Mass.--(BUSINESS WIRE)--Apr 29, 2025-- Access Vascular, Inc. (AVI), a leader in advanced vascular access technology, today announced the presentation of new, expanded real-world data at the 2025 Infusion Nurses Society (INS) Annual Meeting in Las Vegas. The data reinforces significant improvements in midline catheter outcomes associated with AVI's proprietary hydrophilic biomaterial (HBM), building on findings previously shared at the Association for Vascular Access Annual Meeting in 2024. The study was independently designed and conducted by an acute care hospital in Montana and evaluated outcomes across 288 patients. It compared a conventional chlorhexidine gluconate (CHG)-coated polyurethane catheter to Access Vascular's HydroMID® HBM-based catheter. Key findings announced at INS 2025: 'With more than 125 catheters in each study arm, these findings add to the growing body of evidence that our hydrophilic biomaterial platform delivers tangible benefits where it matters most: improved outcomes for patients,' said Jim Biggins, CEO of Access Vascular. 'Fewer complications, longer dwell times, and higher rates of therapy completion all support a safer, more efficient experience for patients and providers alike.' Unlike traditional polyurethane catheters, AVI's devices are constructed from MIMIX®, a proprietary hydrogel-based material designed to reduce thrombus formation and bacterial adhesion. This fundamental material change targets the root causes of vascular access device failure. 'Concerns relating to frequent complications with our previous midline device kept growing. We felt defeated in our efforts to get our patients to the end of their therapy – we knew we could do better for them,' said Kelsey Pearson, RN, VA-BC at Benefis Hospital. 'We have noticed a significant improvement in our outcomes and provided a better patient experience since switching to the HydroMID® catheter.' About Access Vascular Access Vascular, Inc. (AVI) is redefining vascular access by engineering devices from a fundamentally better material. The MIMIX® hydrogel platform is designed to reduce the complications associated with traditional catheters, helping clinicians keep lines in place, improving the patient experience and delivering value to hospitals. For more information, please visit and follow us on LinkedIn. View source version on CONTACT: Media Contact: Brad Perriello Circle Hill Communications [email protected] 617.817.1385 KEYWORD: UNITED STATES NORTH AMERICA NEVADA MASSACHUSETTS INDUSTRY KEYWORD: NURSING MEDICAL SUPPLIES HEALTH MEDICAL DEVICES HOSPITALS HEALTH TECHNOLOGY CARDIOLOGY SOURCE: Access Vascular, Inc. Copyright Business Wire 2025. PUB: 04/29/2025 07:06 AM/DISC: 04/29/2025 07:06 AM
Associated Press
12-02-2025
- Business
- Associated Press
Access Vascular Catheters with MIMIX® Technology Added to Recon Supply's Federal Supply Schedule Contract
BILLERICA, Mass.--(BUSINESS WIRE)--Feb 12, 2025-- Access Vascular, Inc. (AVI), a leader in tackling critical vascular access challenges with its advanced hydrophilic biomaterial technology, today announced that its portfolio of vascular access catheters made with MIMIX® technology has been added to Recon Supply's Federal Supply Schedule (FSS) contract, as well as their Distribution and Pricing Agreement (DAPA) with the Defense Logistics Agency (DLA). This inclusion marks a significant milestone in reducing complication rates for veterans, active-duty military personnel, and other federal healthcare beneficiaries. The FDA-cleared HydroPICC® and HydroMID® catheters feature MIMIX® technology, which has been shown to significantly reduce the most common and costly vascular access complications. This can help healthcare providers save on costs associated with treating complications such as thrombosis, occlusions, and catheter-related failures. 'Our mission at AVI is to improve vascular access outcomes for all patients,' said James Biggins, CEO of Access Vascular. 'We're proud to partner with Recon Supply to bring our MIMIX® catheter family to the FSS contract and DAPA. This addition ensures that the people who serve our nation have access to the gold standard in vascular care.' Joining Recon Supply's FSS contract and DAPA makes AVI's innovative catheters more accessible to federal agencies, including the Dept. of Veterans Affairs (VA), Dept. of Defense (DOD), and Indian Health Services (IHS). These agencies can now procure AVI devices at negotiated pricing, streamlining the process of delivering care to eligible patients. 'Bringing cutting-edge medical technologies to the federal healthcare community is at the core of what we do, and AVI's novel catheter technologies are an excellent example of that,' said Steve Clark, CEO at Recon Supply. 'This collaboration will have a real impact where it matters most, helping to reduce the 25 percent complication rate seen in vascular access devices, and helping to greatly improve patient care.' Access Vascular recently announced data demonstrating 99.99% less bacterial adhesion than both standard polyurethane and CHG-coated polyurethane i in an in vitro study. This data adds to previously published data demonstrating 6X fewer failures than polyurethane and a 98% completion of therapy for HydroMID®. ii About Access Vascular Access Vascular was founded to address the most common and costly complications of intravenous therapy: infection, thrombosis, and phlebitis. Taking a foundationally different approach to thrombus reduction, the company manufactures intravenous catheters from a hydrophilic material. Engineered to mimic the body's natural chemistry, Access Vascular catheters are designed to evade the foreign body response and complications that come with it. Our award-winning, FDA-cleared products are HydroPICC® and HydroMID®. For more information, please visit and follow us on LinkedIn. About Recon Supply Recon Supply is a trusted distributor of medical products and technologies, specializing in providing high-quality solutions to federal agencies and healthcare systems. As a Service-Disabled Veteran-Owned Small Business (SDVOSB), Recon Supply is dedicated to delivering the most innovative medical technologies while actively supporting the veteran community through hiring initiatives. With a focus on excellence and reliability, Recon Supply is committed to enhancing patient care through innovative partnerships. i Korycka, E. (2024). Presented on podium at INS 2024. In vitro data does not necessarily represent clinical outcomes. ii Bunch J. A retrospective assessment of peripheral midline failures focusing on catheter composition. J InfusNurs. Sept/Oct 2022; 45(5):270-27 Brad Perriello Circle Hill Communications 617.817.1385 SOURCE: Access Vascular, Inc. Copyright Business Wire 2025. PUB: 02/12/2025 07:06 AM/DISC: 02/12/2025 07:06 AM
